Indolylazine Derivative Induces Chaperone Expression in Aged Neural Cells and Prevents the Progression of Alzheimer’s Disease
Authors:
- Vladimir F. LazarevVLVladimir F. Lazarev
- Elizaveta A. DutyshevaEDElizaveta A. Dutysheva
- Elena R. MikhaylovaEMElena R. Mikhaylova
- Maria A. TrestsovaMTMaria A. Trestsova
- Irina A. UtepovaIUIrina A. Utepova
- Oleg N. ChupakhinOCOleg N. Chupakhin
- Boris A. MargulisBoris A. Margulis
- Irina V. GuzhovaIGIrina V. Guzhova
Open Access
- 15 December 2022
- Vol. 27 (24) , 8950
Abstract
The risk of progression of most sporadic neurodegenerative diseases, including Alzheimer’s disease, increases with age. Traditionally, this is associated with a decrease in the efficiency of cell protection systems, in particular, molecular chaperones. Thus, the development of small molecules able to induce the synthesis of chaperones is a promising therapeutic approach to prevent neural diseases associated with ageing. Here, we describe a new compound IA-50, belonging to the class of indolylazines and featured by a low size of topological polar surface area, the property related to substances with potentially high membrane-penetrating activity. We also estimated the absorption, distribution, metabolism and excretion characteristics of IA-50 and found the substance to fit the effective drug criteria. The new compound was found to induce the synthesis and accumulation of Hsp70 in normal and aged neurons and in the hippocampi of young and old mice. The transgenic model of Alzheimer’s disease, based on 5xFAD mice, confirmed that the injection of IA-50 prevented the formation of β-amyloid aggregates, loss of hippocampal neurons and the development of memory impairment. These data indicate that this novel substance may induce the expression of chaperones in neural cells and brain tissues, suggesting its possible application in the therapy of ageing-associated disorders.Keywords
Funding Information
- Ministry of Science and Higher Education of Russia (075-15-2020-795)
This publication has 55 references indexed in Scilit:
- Influence of Withania somnifera on obsessive compulsive disorder in miceAsian Pacific Journal of Tropical Medicine, 2012
- Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive functionExperimental & Molecular Medicine, 2012
- Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseasesNature Reviews Drug Discovery, 2011
- Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degenerationProceedings of the National Academy of Sciences, 2011
- A new technology for the synthesis of 4,5,6,7-tetrahydroindoleDoklady Chemistry, 2010
- Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD MicePLOS ONE, 2010
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathologyNature, 2010
- Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effectsCellular & Molecular Biology Letters, 2009
- Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscleBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Serum and lymphocyte levels of heat shock protein 70 in aging: a study in the normal Chinese populationCell Stress and Chaperones, 2004